Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antibody Structure01:10

Antibody Structure

61.8K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
61.8K
Antibody Structure and Classes01:25

Antibody Structure and Classes

5.8K
Antibodies, also known as immunoglobulins, are produced by B cells in response to foreign substances, such as bacteria and viruses. These proteins are critical for recognizing and neutralizing these substances, protecting the body from potential harm.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
5.8K
Protein-Drug Binding: Determination Methods01:22

Protein-Drug Binding: Determination Methods

353
Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
353
Protein Organization01:24

Protein Organization

7.9K
Proteins are polymers of amino acid residues. They are versatile and responsible for different cellular functions, including DNA replication, molecular transport, catalysis, and structural support. Proteins have a hierarchical structure comprising at least three levels of organization: primary, secondary, and tertiary structure. Some large proteins have a quaternary structure where individual protein subunits are linked together.
The primary structure of a protein is its amino acid sequence....
7.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

DEL2PH4: Predictive 3D Pharmacophores from DNA-Encoded Library Screening Data.

ACS medicinal chemistry letters·2026
Same author

SREBP-1 increases glucose uptake to promote tumor resistance to lysosome inhibition.

Science translational medicine·2026
Same author

A Pharmacophore-Based Method for Rapid and Accurate Virtual Screening of Antibody Libraries against Antigens.

Molecular pharmaceutics·2025
Same author

Restoring p53 wild-type conformation in TP53-Y220C-mutant acute myeloid leukemia.

Blood·2025
Same author

Restoration of the Tumor Suppressor Function of Y220C-Mutant p53 by Rezatapopt, a Small-Molecule Reactivator.

Cancer discovery·2025
Same author

Proteomic analysis of ferroptosis pathways reveals a role of CEPT1 in suppressing ferroptosis.

Protein & cell·2024

Related Experiment Video

Updated: Oct 13, 2025

Characterization of Glycoproteins with the Immunoglobulin Fold by X-Ray Crystallography and Biophysical Techniques
08:58

Characterization of Glycoproteins with the Immunoglobulin Fold by X-Ray Crystallography and Biophysical Techniques

Published on: July 5, 2018

12.8K

Functional antibody characterization via direct structural analysis and information-driven protein-protein docking.

Rafael S Depetris1, Dan Lu1, Zhanna Polonskaya1

  • 1Kadmon Corporation, LLC, New York, New York, USA.

Proteins
|November 13, 2021
PubMed
Summary

Researchers developed a computational model for KD035, an antibody targeting vascular endothelial growth factor receptor 2 (VEGFR2). This model aids in understanding antibody-antigen interactions for therapeutic antibody development.

Keywords:
VEGF signalingVEGFR2 clinical antibodyantibody X-ray structure functionantibody-antigen modelingmodel validation studiesmolecular dynamicsprotein complex modeling validation

More Related Videos

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

614
Optimized Negative Staining: a High-throughput Protocol for Examining Small and Asymmetric Protein Structure by Electron Microscopy
09:37

Optimized Negative Staining: a High-throughput Protocol for Examining Small and Asymmetric Protein Structure by Electron Microscopy

Published on: August 15, 2014

44.1K

Related Experiment Videos

Last Updated: Oct 13, 2025

Characterization of Glycoproteins with the Immunoglobulin Fold by X-Ray Crystallography and Biophysical Techniques
08:58

Characterization of Glycoproteins with the Immunoglobulin Fold by X-Ray Crystallography and Biophysical Techniques

Published on: July 5, 2018

12.8K
Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

614
Optimized Negative Staining: a High-throughput Protocol for Examining Small and Asymmetric Protein Structure by Electron Microscopy
09:37

Optimized Negative Staining: a High-throughput Protocol for Examining Small and Asymmetric Protein Structure by Electron Microscopy

Published on: August 15, 2014

44.1K

Area of Science:

  • Immunology
  • Computational Biology
  • Structural Biology

Background:

  • Understanding therapeutic antibody mechanisms is crucial for drug development.
  • KD035 is a fully human antibody targeting vascular endothelial growth factor receptor 2 (VEGFR2).
  • KD035 inhibits VEGF-A and VEGF-C mediated VEGFR2 activation.

Purpose of the Study:

  • To create a computational model of the complex between KD035 variable fragment (KD035(Fv)) and VEGFR2 domains 2 and 3 (VEGFR2(D2-3)).
  • To provide a validated in silico method for antibody-antigen complex modeling.

Main Methods:

  • Utilized experimental data including X-ray structures, binding assays, and domain mapping to guide computational modeling.
  • Employed molecular dynamics simulations to assess model accuracy.
  • Validated the model through mutagenesis and binding analysis.

Main Results:

  • A computational model of the KD035(Fv)-VEGFR2(D2-3) complex was successfully generated.
  • The model's accuracy was confirmed through simulations and experimental validation.
  • The methodology provides a robust framework for future protein-protein complex modeling.

Conclusions:

  • The developed computational model accurately represents the KD035-VEGFR2 interaction.
  • This in silico approach offers a valuable tool for characterizing therapeutic antibodies.
  • The established modeling strategy can be applied to other antibody-antigen systems and protein complexes.